ϟ
 
DOI: 10.1055/s-0031-1275829
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.

Wahrnehmung der Schutzimpfung gegen die Neue Grippe H1N1 von Patienten mit Morbus Crohn oder Colitis ulcerosa

Niels Teich,Carsten Schmidt,Andreas Stallmach,Tobias Klugmann,M Vieth,DC Baumgart,Andreas Sturm,G Felten,Dietrich Hüppe,Joerg Emmrich,Ulrich Böcker,Christian Maaser,Elke Bästlein,Robert Ehehalt,Thomas Krummenerl,Oliver Bachmann,Wolfgang Kruis,Michael Mroß,K Herrlinger,Ulf Helwig,Jürgen Büning,Jens Aschenbeck,Britta Siegmund,J Preiß,Jochen Maul,R Drossel,I Schiefke,Max Reinshagen,Jan Heidemann,Andreas Lügering,Kai-Uwe Rehbehn,A. Pfeiffer,Petra Jessen,Stefan Schreiber,B Rosezin,Axel Dignaß,Stephan Böhm,B. Bokemeyer

Medicine
Vaccination
Ulcerative colitis
2011
In September 2009, the German "Standing Committee for Vaccination" (STIKO) recommended the H1N1 influenza vaccination to all patients with chronic diseases. We investigated the adherence to this recommendation in patients with the inflammatory bowel diseases (IBD) Crohn's disease or ulcerative colitis. Special attention was paid to arguments for vaccination refusal.In an explorative multicenter study we asked adult patients to answer a questionnaire about their participation in the H1N1 vaccination campaign, their arguments for and against this vaccination and disease specific parameters.Out of 1389 participating patients, 226 (16 %) received the H1N1 vaccination. Among patients who were vaccinated against the seasonal flu as well as patients who were treated with anti-TNF-treatment and members of the German Crohn's and Colitis Association, the participation rates were significantly higher (32 %, 26 %, 25 %, respectively). The main argument against the H1N1 vaccination was fear of side effects (59 %). However, 77 % of all vaccinated patients judged the vaccine as very well tolerated. The non-adherence to general vaccination recommendations against tetanus and seasonal flu was also high (25 % and 66 %, respectively).Only a minority of patients with Crohn's disease or ulcerative colitis had adhered to the official recommendation concerning vaccination against H1N1. In order to reach higher acceptance, further vaccination campaigns must focus on the safety of the recommended vaccine.
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    Wahrnehmung der Schutzimpfung gegen die Neue Grippe H1N1 von Patienten mit Morbus Crohn oder Colitis ulcerosa” is a paper by Niels Teich Carsten Schmidt Andreas Stallmach Tobias Klugmann M Vieth DC Baumgart Andreas Sturm G Felten Dietrich Hüppe Joerg Emmrich Ulrich Böcker Christian Maaser Elke Bästlein Robert Ehehalt Thomas Krummenerl Oliver Bachmann Wolfgang Kruis Michael Mroß K Herrlinger Ulf Helwig Jürgen Büning Jens Aschenbeck Britta Siegmund J Preiß Jochen Maul R Drossel I Schiefke Max Reinshagen Jan Heidemann Andreas Lügering Kai-Uwe Rehbehn A. Pfeiffer Petra Jessen Stefan Schreiber B Rosezin Axel Dignaß Stephan Böhm B. Bokemeyer published in 2011. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.